珀金埃尔默新型冠状病毒核酸检测试剂盒获得美国食品药品管理局批准紧急使用授权
3月24日,作为始终致力于为创建更健康的世界而持续创新的全球领导者,珀金埃尔默宣布,美国食品药品管理局(FDA)已为公司研发的新型冠状病毒核酸检测试剂盒(RT-PCR)批准了紧急使用授权(EUA)。
We're Moving to
The content you are trying to access has moved to new site. Explore, discover (and in certain contries, buy) our products and services on our new website. Click to visit now or you will be automatically redirected.
to view non-migrated solutions
There is a famous photo of a young David Vetter staring out from inside his sterile plastic bubble in 1983. His piercing, dark eyes and haunting look tug at your heartstrings. Dubbed “bubble boy” by the media, David suffered from Severe Combined Immunodeficiency, or SCID, disease. Not long after the photo, David died from lymphoma.
SCID affects 1 in every 50,000 to 100,000 births. It is a primary immunodeficiency disorder leaving infants with few or no T lymphocytes that help resist infections. Several different genetic defects cause SCID. Untreated, SCID is usually fatal. If detected within the first few weeks of life, however, cord blood or bone marrow transplants can treat and even cure the disease.
More than 30 years after “Bubble Boy’s” passing, children with SCID and their families now have reason to hope. In both the United States and Canada, PerkinElmer has received authorization to offer its newborn screening kit for SCID to healthcare professionals throughout the two countries. With these recent approvals, PerkinElmer’s VICTOR™ EnLite™ and EnLite™ Neonatal TREC kit is now providing SCID screening in more than 30 countries around the world.
EnLite™ Neonatal TREC brochure – (outside US and Canada)
EnLite™ Neonatal TREC brochure – (US and Canada only)
3月24日,作为始终致力于为创建更健康的世界而持续创新的全球领导者,珀金埃尔默宣布,美国食品药品管理局(FDA)已为公司研发的新型冠状病毒核酸检测试剂盒(RT-PCR)批准了紧急使用授权(EUA)。
致力于为创建更健康的世界而不懈努力的全球技术领导企业珀金埃尔默,今天宣布推出PaddyCheck™ PC 6800米质分析仪。这一全新的解决方案综合利用了图像分析法和压力测试法,可加快样品分析通量,提高准确度,为更加一致的稻米品质评价提供标准化结果。
PerkinElmer科学家已经与威尔士大学医院和卡迪夫大学的科研人员合作,共同开发了一款针对杜氏肌营养不良症的新型免疫分析筛查测试。
菲律宾正在庆祝新生儿筛查二十周年,宣布将进一步扩大该计划及其目标。